Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
01-2003 | 10-2002 | 07-2002 | 04-2002 | 01-2002 | |
Cash Flows From Operating Activities | |||||
Net Income | -41,500 | -980,200 | -763,100 | -134,000 | -44,800 |
Depreciation Amortization | 15,300 | 100,800 | 119,700 | 58,000 | 27,700 |
Income taxes - deferred | N/A | 498,100 | 474,100 | -1,500 | -900 |
Accounts receivable | 24,100 | 106,000 | 126,900 | 117,600 | 79,900 |
Accounts payable and accrued liabilities | -17,400 | -77,100 | -80,200 | -57,100 | -54,600 |
Other Working Capital | 61,200 | 15,700 | 128,200 | 261,900 | 146,300 |
Other Operating Activity | 8,500 | 396,400 | 159,400 | -30,400 | -21,500 |
Operating Cash Flow | $50,200 | $59,700 | $165,000 | $214,500 | $132,100 |
Cash Flows From Investing Activities | |||||
PPE Investments | -5,700 | -25,600 | -30,100 | -21,800 | -16,600 |
Net Acquisitions | 500 | -1,900 | -3,200 | -4,300 | -3,900 |
Sale Of Investment | 4,000 | 70,900 | 65,700 | 30,400 | 6,600 |
Other Investing Activity | 34,500 | -177,000 | -276,500 | -260,100 | 0 |
Investing Cash Flow | $33,300 | $-133,600 | $-244,100 | $-255,800 | $-13,900 |
Cash Flows From Financing Activities | |||||
Debt Issued | 3,100 | -5,200 | -4,100 | N/A | -2,000 |
Debt Repayment | N/A | N/A | N/A | -3,900 | N/A |
Common Stock Issued | 300 | 9,100 | 6,500 | 6,300 | 600 |
Financing Cash Flow | $3,400 | $3,900 | $2,400 | $2,400 | $-1,400 |
Exchange Rate Effect | 500 | 200 | -100 | -200 | 300 |
Beginning Cash Position | 278,900 | 347,500 | 348,600 | 348,600 | 348,600 |
End Cash Position | 366,300 | 277,700 | 271,800 | 309,500 | 465,700 |
Net Cash Flow | $87,400 | $-69,800 | $-76,800 | $-39,100 | $117,100 |
Free Cash Flow | |||||
Operating Cash Flow | 50,200 | 59,700 | 165,000 | 214,500 | 132,100 |
Capital Expenditure | -5,700 | -25,600 | -30,100 | -21,800 | -16,600 |
Free Cash Flow | 44,500 | 34,100 | 134,900 | 192,700 | 115,500 |